1. Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer.

Agnelli G, Becattini C, Meyer G, Muñoz A, Huisman MV, Connors JM, Cohen A, Bauersachs R, Brenner B, Torbicki A, Sueiro MR, Lambert C, Gussoni G, Campanini M, Fontanella A, Vescovo G, Verso M ; Caravaggio Investigators.

N Engl J Med. 2020 Apr 23; 382 (17): 1599-1607. doi: 10.1056 / NEJMoa1915103. Epub 2020 Mar 29.

2. Abnormal ankle-brachial index (ABI) predicts primary and secondary cardiovascular risk and cancer mortality.

Visonà A, De Paoli A, Fedeli U, Tonello D, Zalunardo B, Zanatta N, Martini R, Pesavento R, Cuppini S, Prior M, Benazzi S, Cimminiello C, Avossa F.

Eur J Intern Med. 2020 Mar 6.

3. Upper extremity deep vein thrombosis treated with direct oral anticoagulants: a multi-center real world experience.

Porfidia A, Agostini F, Giarretta I, Tonello D, Pastori D, Pignatelli P, Santoliquido A, Sartori M, Lessiani G, Visonà A, Donadini MP, Pola R.

J Thromb Thrombolysis. 2020 Feb 1

4. Correction to: Vena cava filters in patients presenting with major bleeding during anticoagulation for venous thromboembolism.

Mellado M, Trujillo-Santos J, Bikdeli B, Jiménez D, Núñez MJ, Ellis M, Marchena PJ, Vela JR, Clara A, Moustafa F, Monreal M; RIETE Investigators.

Intern Emerg Med. 2019 Oct; 14 (7): 1991

5. Prediction of early mortality in patients with cancer-associated thrombosis in the RIETE Database.

Fuentes HE, Tafur AJ, Caprini JA, Alatri A, Trujillo-Santos J, Farge-Bancel D, Rosa V, Font L, Vilaseca A, Monreal M; RIETE Investigators.

Int Angiol. 2019 Jun; 38 (3): 173-184.

6. Vena cava filters in patients presenting with major bleeding during anticoagulation for venous thromboembolism.

Mellado M, Trujillo-Santos J, Bikdeli B, Jiménez D, Núñez MJ, Ellis M, Marchena PJ, Vela JR, Clara A, Moustafa F, Monreal M; RIETE Investigators.

Intern Emerg Med. 2019 May 3.

7. Rate and duration of hospitalization for acute pulmonary embolism in the real-world clinical practice of different countries: analysis from the RIETE registry.

Mastroiacovo D, Dentali F, di Micco P, Maestre A, Jiménez D, Soler S, Sahuquillo JC, Verhamme P, Fidalgo Á, López-Sáez JB, Skride A, Monreal M; RIETE Investigators; Coordinator of the RIETE Registry: Manuel Monreal (Spain). RIETE Steering Committee Members :; Members of the RIETE Group are as follows. Spain :.

Eur Respir J. 2019 Feb 21; 53 (2).

8. Microparticles Carrying Sonic Hedgehog Are Increased in Humans with Peripheral Artery Disease.

Giarretta I, Gatto I, Marcantoni M, Lupi G, Tonello D, Gaetani E, Pitocco D, Iezzi R, Truma A, Porfidia A, Visonà A, Tondi P, Pola R.

Int J Mol Sci. 2018 Dec 9; 19 (12).

9. Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism.

Moustafa F, Giorgi Pierfranceschi M, Di Micco P, Bucherini E, Lorenzo A, Villalobos A, Nieto JA, Valero B, Sampériz ÁL, Monreal M; RIETE Investigators.

Res Pract Thromb Haemost. 2017 Sep 4; 1 (2): 172-179. doi: 10.1002 / rth2.12036. eCollection 2017 Oct.

10. Anemia and bleeding in patients receiving anticoagulant therapy for venous thromboembolism.

Kuperman A, López-Reyes R, Bosco LJ, Lorenzo A, José B, Farge Bancel D, Alfonso M, Lumbierres M, Stemer G, Monreal Bosch M, Braester A; RIETE Investigators.

J Thromb Thrombolysis. 2018 Apr; 45 (3): 360-368. doi: 10.1007 / s11239-018-1610-9.

11. Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism.

Chai-Adisaksopha C, Iorio A, Crowther MA, de Miguel J, Salgado E, Zdraveska M, Fernández-Capitán C, Nieto JA, Barillari G, Bertoletti L, Monreal M; REETE investigators.

Am J Med. 2018 Apr; 131 (4): 430-437.

12. Erratum to "Choices of Stent and Cerebral Protection in the Ongoing ACST-2 Trial: A Descriptive Study" [Eur J Vasc Endovasc Surg 53 (2017) 617-625].

de Waard DD, Halliday A, de Borst GJ, Bulbulia R, Huibers A, Casana R, Bonati LH, Tolva V; ACST-2 Collaborative Group.

Eur J Vasc Endovasc Surg. 2017 Sep; 54 (3): 407.

13. Choices of Stent and Cerebral Protection in the Ongoing ACST-2 Trial: A Descriptive Study.

de Waard DD, Halliday A, de Borst GJ, Bulbulia R, Huibers A, Casana R, Bonati LH, Tolva V; ACST-2 Collaborative Group.

Eur J Vasc Endovasc Surg. 2017 May; 53 (5): 617-625.

14. Treatment of Right Heart Thrombi Associated with Acute Pulmonary Embolism.

Barrios D, Chavant J, Jiménez D, Bertoletti L, Rosa-Salazar V, Muriel A, Viallon A, Fernández-Capitán C, Yusen RD, Monreal M; Informatizado Register of the Enfermedad TromboEmbólica Investigators.

Am J Med. 2017 May; 130 (5): 588-595.

15. Analysis of noncatheter-associated upper extremity deep venous thrombosis from the RIETE registry.

Newton DH, Monreal Bosch M, Amendola M, Wolfe L, Perez Ductor C, Lecumberri R, Levy MM; RIETE Investigators.

J Vasc Surg Venous Lymphat Disord. 2017 Jan; 5 (1): 18-24.

16. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation.

Tzoran I, Papadakis M, Brenner B, Fidalgo Á, Rivas A, Wells PS, Gavín O, Adarraga MD, Moustafa F, Monreal M; Register Informatizado de Enfermedad TromboEmbólica Investigators.

Am J Med. 2017 Apr; 130 (4): 482.e1-482.e9.

17. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE.

Jara-Palomares L, Otero R, Jimenez D, Carrier M, Tzoran I, Brenner B, Margeli M, Praena-Fernandez JM, Grandone E, Monreal M; RIETE Investigators.

Chest. 2017 Mar; 151 (3): 564-571.

18. Patterns and determinants of use of pharmacological therapies for intermittent claudication in PAD outpatients: results of the IDOMENEO study.

Cimminiello C, Polo Friz H, Marano G, Arpaia G, Boracchi P, Spezzigu G, Visonà A; SIAPAV Investigators.

Int Angiol. 2017 Jun; 36 (3): 254-260.

19. DVT Management and Outcome Trends, 2001 to 2014.

Morillo R, Jiménez D, Aibar MÁ, Mastroiacovo D, Wells PS, Sampériz Á, Saraiva de Sousa M, Muriel A, Yusen RD, Monreal M; REETE investigators.

Chest. 2016 Aug; 150 (2): 374-83.

20. Subsequent arterial ischemic events in patients receiving anticoagulant therapy for venous thromboembolism.

Madridano O, del Toro J, Lorenzo A, Martín M, Gómez Cerezo J, Hernández L, Prandoni P, Monreal M; RIETE Investigators.

J Vasc Surg Venous Lymphat Disord. 2015 Apr; 3 (2): 135-41.

21. A RIETE registry analysis of recurrent thromboembolism and hemorrhage in patients with catheter-related thrombosis.

Baumann Kreuziger L, Cote L, Verhamme P, Greenberg S, Caprini J, Muñoz FJ, Valle R, Monreal Bosch M; RIETE Investigators.

J Vasc Surg Venous Lymphat Disord. 2015 Jul; 3 (3): 243-50.

22. Platelet Count and Major Bleeding in Patients Receiving Vitamin K Antagonists for Acute Venous Thromboembolism, Findings From Real World Clinical Practice.

Giorgi-Pierfranceschi M, Di Micco P, Cattabiani C, Guida A, Pagán B, Morales Mdel V, Salgado E, Suriñach JM, Tolosa C, Monreal M; RIETE Investigators.

Medicine (Baltimore). 2015 Nov; 94 (47):

23. Venous thromboembolism in patients with glioblastoma multiforme: Findings of the RIETE registry.

Portillo J, de la Rocha IV, Font L, Braester A, Madridano O, Peromingo JA, Apollonio A, Pagán B, Bascuñana J, Monreal M; RIETE Investigations.

Thromb Res. 2015 Dec; 136 (6): 1199-203.

24. Infection as cause of immobility and occurrence of venous thromboembolism: analysis of 1635 medical cases from the RIETE registry.

Frasson S, Gussoni G, Di Micco P, Barba R, Bertoletti L, Nuñez MJ, Valero B, Samperiz AL, Rivas A, Monreal M; RIETE Investigators.

J Thromb Thrombolysis. 2016 Apr; 41 (3): 404-12.

25. Identification of Low-Risk Patients with Acute Symptomatic Pulmonary Embolism for Outpatient Therapy.

Maestre A, Trujillo-Santos J, Riera-Mestre A, Jiménez D, Di Micco P, Bascuñana J, Vela JR, Peris L, Malfante PC, Monreal M; RIETE Investigators.

Ann Am Thorac Soc. 2015 Aug; 12 (8): 1122-9.

26. Long-Term Anticoagulant Therapy of Patients with Venous Thromboembolism. What Are the Practices?

Mahé I, Sterpu R, Bertoletti L, López-Jiménez L, Mellado Joan M, Trujillo-Santos J, Ballaz A, Hernández Blasco LM, Marchena PJ, Monreal M; RIETE Investigators.

PLoS One. 2015 Jun 15; 10 (6): e0128741.

27. Venous thromboembolism in patients immobilized at home.

López-Reyes R, Nauffal D, Ballester M, Martín-Antorán JM, de Sousa MS, Riera-Mestre A, Ruiz-Ruiz J, Fernández-Capitán C, Uresandi F, Monreal M; REETE investigators.

Eur Respir J. 2015 Jun; 45 (6): 1728-31.

28. Duration of anticoagulation after venous thromboembolism in real world clinical practice.

Ageno W, Samperiz A, Caballero R, Dentali F, Di Micco P, Prandoni P, Becattini C, Uresandi F, Verhamme P, Monreal M; REETE investigators.

Thromb Res. 2015 Apr; 135 (4): 666-72.

29. Sex differences in patients receiving anticoagulant therapy for venous thromboembolism.

Blanco-Molina A, Enea I, Gadelha T, Tufano A, Bura-Riviere A, Di Micco P, Bounameaux H, González J, Villalta J, Monreal M; RIETE Investigators.

Medicine (Baltimore). 2014 Oct; 93 (17): 309-17.

30. Clinical outcome in patients with venous thromboembolism receiving concomitant anticoagulant and antiplatelet therapy.

Tzoran I, Brenner B, Sakharov G, Trujillo-Santos J, Lorenzo A, Madridano O, López-Sáez JB, Monreal M; REETE investigators.

Eur J Intern Med. 2014 Nov; 25 (9): 821-5.

31. A prognostic score to identify low-risk outpatients with acute deep vein thrombosis in the lower limbs.

Trujillo-Santos J, Lozano F, Lorente MA, Adarraga D, Hirmerova J, Del Toro J, Mazzolai L, Barillari G, Barrón M, Monreal M; RIETE Investigators.

Am J Med. 2015 Jan; 128 (1): 90.e9-15.

32. Influence of recent immobilization or surgery on mortality in cancer patients with venous thromboembolism.

Trujillo-Santos J, Gussoni G, Gadelha T, Sänchez Muñoz-Torrero JF, Barron M, Lopez L, Ruiz-Ruiz J, Fernandez-Capitan C, Lorente M, Monreal M; RIETE Investigators.

Thromb Res. 2014 May; 133 Suppl 2: S29-34.

33. Comparison of four scores to predict major bleeding in patients receiving anticoagulation for venous thromboembolism: findings from the RIETE registry.

Piovella C, Dalla Valle F, Trujillo-Santos J, Pesavento R, López L, Font L, Valle R, Nauffal D, Monreal M, Prandoni P; RIETE Investigators.

Intern Emerg Med. 2014 Dec; 9 (8): 847-52.

34. Outcomes in neurosurgical patients who develop venous thromboembolism: a review of the RIETE registry.

Cote LP, Greenberg S, Caprini JA, Stone J, Arcelus JI, López-Jiménez L, Rosa V, Schellong S, Monreal M; RIETE Investigators.

Clin Appl Thromb Hemost. 2014 Nov; 20 (8): 772-8.

35. Home versus in-hospital treatment of outpatients with acute deep venous thrombosis of the lower limbs.

Lozano F, Trujillo-Santos J, Barrón M, Gallego P, Babalis D, Santos M, Falgá C, Monreal M; RIETE Investigators.

J Vasc Surg. 2014 May; 59 (5): 1362-7.

36. D-dimer levels and 90-day outcome in patients with acute pulmonary embolism with or without cancer.

Maestre A, Trujillo-Santos J, Visoná A, Lobo JL, Grau E, Malý R, Duce R, Monreal M; RIETE Investigators.

Thromb Res. 2014 Mar; 133 (3): 384-9.

37. Platelet count and outcome in patients with acute venous thromboembolism.

Di Micco P, Ruiz-Giménez N, Nieto JA, Aujesky D, del Molino F, Valle R, Barrón M, Maestre A, Monreal M; REETE investigators.

Thromb Haemost. 2013 Nov; 110 (5): 1025-34.

38. Pulmonary embolism and 3-month outcomes in 4036 patients with venous thromboembolism and chronic obstructive pulmonary disease: data from the RIETE registry.

Bertoletti L, Quenet S, Laporte S, Sahuquillo JC, Conget F, Pedrajas JM, Martin M, Casado I, Riera-Mestre A, Monreal M; RIETE Investigators.

Respir Res. 2013 Jul 18; 14: 75.

39. Validation of a score for predicting fatal bleeding in patients receiving anticoagulation for venous thromboembolism.

Nieto JA, Solano R, Trapero Iglesias N, Ruiz-Giménez N, Fernández-Capitán C, Valero B, Tiberio G, Bura-Riviere A, Monreal M; RIETE Investigators.

Thromb Res. 2013 Aug; 132 (2): 175-9.

40. Dynamics of case-fatalilty rates of recurrent thromboembolism and major bleeding in patients treated for venous thromboembolism.

Lecumberri R, Alfonso A, Jiménez D, Fernández Capitán C, Prandoni P, Wells PS, Vidal G, Barillari G, Monreal M; REETE investigators.

Thromb Haemost. 2013 Oct; 110 (4): 834-43.

41. Low-molecular-weight or unfractionated heparin in venous thromboembolism: the influence of renal function.

Trujillo-Santos J, Schellong S, Falga C, Zorrilla V, Gallego P, Barrón M, Monreal M; RIETE Investigators.

Am J Med. 2013 May; 126 (5): 425-434.e1

42. Factors associated with elevated pulmonary arterial pressure levels on the echocardiographic assessment in patients with prior pulmonary embolism.

Otero R, Elías T, Jara L, Trujillo-Santos J, Bertoletti L, Nauffal D, Ruiz-Ruiz J, Blanco-Molina Á, Monreal M; REETE investigators.

Thromb Res. 2013 May; 131 (5): e191-5.

43. Unsuspected pulmonary embolism in patients with cancer.

Soler S, Delgado C, Ballaz A, Cisneros E, Malý R, Babalis D, Monréal M; RIETE Investigators.

Thromb Res. 2012 Apr; 129 Suppl 1: S16-9.

44. Thrombolytic therapy and outcome of patients with an acute symptomatic pulmonary embolism.

Riera-Mestre A, Jiménez D, Muriel A, Lobo JL, Moores L, Yusen RD, Casado I, Nauffal D, Oribe M, Monreal M; REETE investigators.

J Thromb Haemost. 2012 May; 10 (5): 751-9.

45. Venous thromboembolism in immobilized patients with dementia. Findings from the RIETE registry.

Nuñez MJ, Villalba JC, Cebrián E, Visoná A, Lopez-Jimenez L, Núñez M, Szwebel TA, Luque JM, Jaras MJ, Monreal M; RIETE Investigators.

Thromb Res. 2012 Aug; 130 (2): 173-7.

46. Natural history of patients developing thrombocytopenia while receiving anticoagulant therapy for venous thromboembolism.

Di Micco P, Fontanella A, Falvo N, Bonithon-Kopp C, Decousus H, Riera-Mestre A, Monreal M; RIETE Investigators.

Int Angiol. 2012 Feb; 31 (1): 92-5.

47. Silent pulmonary embolism in patients with proximal deep vein thrombosis in the lower limbs.

Tzoran I, Saharov G, Brenner B, Delsart D, Román P, Visoná A, Jiménez D, Monreal M; RIETE Investigators.

J Thromb Haemost. 2012 Apr; 10 (4): 564-71.

48. Venous thromboembolism in patients with intracranial haemorrhage.

Lobo JL, Nieto JA, Zorrilla V, Garrido N, Madridano O, Ruiz J, Farge-Bancel D, Tiberio G, Uresandi F, Monreal M; RIETE Investigators.

Thromb Haemost. 2011 Oct; 106 (4): 750-2

49. Clinical presentation and outcome of venous thromboembolism in COPD.

Bertoletti L, Quenet S, Mismetti P, Hernández L, Martín-Villasclaras JJ, Tolosa C, Valdés M, Barrón M, Todolí JA, Monreal M; RIETE Investigators.

Eur Respir J. 2012 Apr; 39 (4): 862-8.

50. The efficacy of statin therapy in patients with acute coronary syndromes and concomitant carotid disease.

Komorovsky R, Desideri A, Coscarelli S, Tonello D, Visonà A, Celegon L.

Clin Cardiol. 2010 Feb; 33 (2): E15-9.

51. Antithrombotic treatment before and after peripheral artery percutaneous angioplasty.

Visonà A, Tonello D, Zalunardo B, Irsara S, Liessi G, Marigo L, Zotta L.

Blood Transfus. 2009 Jan; 7 (1): 18-23.

52. Early mobilization after percutaneous catheterization and vascular closure with a novel device (Star-Close).

Wishes A, Tonello D, Coscarelli S, Alitto F, Daniotti A, Chioin R.

Am J Cardiol. 2005 Nov 15; 96 (10): 1408-9.

53. Prognostic implications of sonographic characteristics of carotid plaques in patients with acute coronary syndromes.

Komorovsky R, Desideri A, Coscarelli S, Cortigiani L, Tonello D, Visonà A, Celegon L.

Heart. 2005 Jun; 91 (6): 819-20

54. Predictive value of associations between carotid and coronary artery disease in patients with acute coronary syndromes.

Komorovsky R, Desideri A, Coscarelli S, Cortigiani L, Tonello D, Visonà A, Celegon L.

Am J Cardiol. 2005 Jan 1; 95 (1): 116-9.

55. Local photodynamic therapy with Zn (II) -phthalocyanine in an experimental model of intimal hyperplasia.

Visonà A, Angelini A, Gobbo S, Bonanome A, Thiene G, Pagnan A, Tonello D, Bonandini E, Jori G.

J Photochem Photobiol B. 2000 Sep; 57 (2-3): 94-101.